More importantly, blocking MHC‐I‐LILRB1 signaling pathway also contributes to NK cell‐mediated anti‐tumor response.[217] Therefore, the tumor‐inhibiting response initiated by blocking MHC‐I‐LILRB1 axis may be a synergetic effect of macrophages and NK cells. The gene discussed is LILRB1; the disease is neoplasm.